(5-Chloro-2-(2-(methylamino)thiazol-4-yl)pyridin-4-yl)(4-(4-chlorobenzyl)piperazin-1-yl)methanone

Catalog No. :
ACZITE107
CAS No. :
2123489-30-3
Molecular Formula :
C21H21Cl2N5OS
Molecular Weight :
462.41

IUPAC Name:(5-chloro-2-(2-(methylamino)thiazol-4-yl)pyridin-4-yl)(4-(4-chlorobenzyl)piperazin-1-yl)methanone

(5-Chloro-2-(2-(methylamino)thiazol-4-yl)pyridin-4-yl)(4-(4-chlorobenzyl)piperazin-1-yl)methanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5-Chloro-2-(2-(methylamino)thiazol-4-yl)pyridin-4-yl)(4-(4-chlorobenzyl)piperazin-1-yl)methanone
IUPAC Name(5-chloro-2-(2-(methylamino)thiazol-4-yl)pyridin-4-yl)(4-(4-chlorobenzyl)piperazin-1-yl)methanone
Molecular FormulaC21H21Cl2N5OS
Molecular Weight462.41
SMILESO=C(C1=CC(C2=CSC(NC)=N2)=NC=C1Cl)N3CCN(CC4=CC=C(Cl)C=C4)CC3
InChI KeyMVXAYIXYYOVALX-UHFFFAOYSA-N
SynonymMethanone,[5-​chloro-​2-​[2-​(methylamino)​-​4-​thiazolyl]​-​4-​pyridinyl]​[4-​[(4-​chlorophenyl)​methyl]​-​1-​piperazinyl]​-
CAS No.2123489-30-3
PubChem CID133080583

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACZITE107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZITE107 route product structure diagram
    ACZITE1072123489-30-3
Inquiry

2. ACZITE107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZITE107 route product structure diagram
    ACZITE1072123489-30-3
Inquiry

Comments (0)